#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=4. Molecular Mechanisms of Trichothecene Resistance
1-1	0-2	4.	_	_	_	_
1-2	3-12	Molecular	abstract[1]	new[1]	_	_
1-3	13-23	Mechanisms	abstract[1]	new[1]	_	_
1-4	24-26	of	abstract[1]	new[1]	_	_
1-5	27-40	Trichothecene	abstract[1]|place|organization[3]	new[1]|new|new[3]	coref|coref	2-2|2-2[5_3]
1-6	41-51	Resistance	abstract[1]|organization[3]	new[1]|new[3]	_	_

#Text=4.1. Trichothecene Resistance at the Ribosome
2-1	52-56	4.1.	_	_	_	_
2-2	57-70	Trichothecene	place|organization[5]	giv|giv[5]	coref	18-37
2-3	71-81	Resistance	organization[5]	giv[5]	_	_
2-4	82-84	at	organization[5]	giv[5]	_	_
2-5	85-88	the	organization[5]|abstract[6]	giv[5]|new[6]	coref	3-9[8_6]
2-6	89-97	Ribosome	organization[5]|abstract[6]	giv[5]|new[6]	_	_

#Text=Owing to the ubiquitous and essential activities of the ribosome , its structure is highly conserved within phylogenetic domains , making it a reliable target for pathogens .
3-1	98-103	Owing	_	_	_	_
3-2	104-106	to	_	_	_	_
3-3	107-110	the	abstract[7]	new[7]	_	_
3-4	111-121	ubiquitous	abstract[7]	new[7]	_	_
3-5	122-125	and	abstract[7]	new[7]	_	_
3-6	126-135	essential	abstract[7]	new[7]	_	_
3-7	136-146	activities	abstract[7]	new[7]	_	_
3-8	147-149	of	abstract[7]	new[7]	_	_
3-9	150-153	the	abstract[7]|abstract[8]	new[7]|giv[8]	ana	3-12[0_8]
3-10	154-162	ribosome	abstract[7]|abstract[8]	new[7]|giv[8]	_	_
3-11	163-164	,	_	_	_	_
3-12	165-168	its	abstract|abstract[10]	giv|new[10]	ana	3-22
3-13	169-178	structure	abstract[10]	new[10]	_	_
3-14	179-181	is	_	_	_	_
3-15	182-188	highly	_	_	_	_
3-16	189-198	conserved	_	_	_	_
3-17	199-205	within	_	_	_	_
3-18	206-218	phylogenetic	abstract[11]	new[11]	_	_
3-19	219-226	domains	abstract[11]	new[11]	_	_
3-20	227-228	,	_	_	_	_
3-21	229-235	making	_	_	_	_
3-22	236-238	it	abstract	giv	coref	4-1[14_0]
3-23	239-240	a	_	_	_	_
3-24	241-249	reliable	_	_	_	_
3-25	250-256	target	_	_	_	_
3-26	257-260	for	_	_	_	_
3-27	261-270	pathogens	animal	new	_	_
3-28	271-272	.	_	_	_	_

#Text=The ribosome can resist the effect of trichothecenes if a point mutation occurs at the tryptophan ( W ) residue within the highly conserved W-finger of Ribosomal Protein L3 ( RPL3 ) .
4-1	273-276	The	abstract[14]	giv[14]	coref	17-15[162_14]
4-2	277-285	ribosome	abstract[14]	giv[14]	_	_
4-3	286-289	can	_	_	_	_
4-4	290-296	resist	_	_	_	_
4-5	297-300	the	abstract[15]	new[15]	coref	11-20[92_15]
4-6	301-307	effect	abstract[15]	new[15]	_	_
4-7	308-310	of	abstract[15]	new[15]	_	_
4-8	311-325	trichothecenes	abstract[15]|substance	new[15]|new	_	_
4-9	326-328	if	_	_	_	_
4-10	329-330	a	event[18]	new[18]	coref	8-16[61_18]
4-11	331-336	point	abstract|event[18]	new|new[18]	_	_
4-12	337-345	mutation	event[18]	new[18]	_	_
4-13	346-352	occurs	_	_	_	_
4-14	353-355	at	_	_	_	_
4-15	356-359	the	abstract[21]	new[21]	_	_
4-16	360-370	tryptophan	substance|abstract[21]	new|new[21]	coref	7-6[49_0]
4-17	371-372	(	abstract[21]	new[21]	_	_
4-18	373-374	W	person|abstract[21]	new|new[21]	_	_
4-19	375-376	)	abstract[21]	new[21]	_	_
4-20	377-384	residue	abstract[21]	new[21]	_	_
4-21	385-391	within	abstract[21]	new[21]	_	_
4-22	392-395	the	abstract[21]|abstract[22]	new[21]|new[22]	coref	6-1[36_22]
4-23	396-402	highly	abstract[21]|abstract[22]	new[21]|new[22]	_	_
4-24	403-412	conserved	abstract[21]|abstract[22]	new[21]|new[22]	_	_
4-25	413-421	W-finger	abstract[21]|abstract[22]	new[21]|new[22]	_	_
4-26	422-424	of	abstract[21]|abstract[22]	new[21]|new[22]	_	_
4-27	425-434	Ribosomal	abstract[21]|abstract[22]|animal|substance[24]	new[21]|new[22]|new|new[24]	coref	6-10[39_24]
4-28	435-442	Protein	abstract[21]|abstract[22]|substance[24]	new[21]|new[22]|new[24]	_	_
4-29	443-445	L3	abstract[21]|abstract[22]|substance[24]	new[21]|new[22]|new[24]	_	_
4-30	446-447	(	_	_	_	_
4-31	448-452	RPL3	abstract	new	coref	6-11
4-32	453-454	)	_	_	_	_
4-33	455-456	.	_	_	_	_

#Text=Mutations at this site also confer resistance to other “ antibiotics ” [ e.g. , anisomycin , 211 ] , that bind the A-site of the peptidyl transferase center .
5-1	457-466	Mutations	abstract[26]	new[26]	coref	9-6[67_26]
5-2	467-469	at	abstract[26]	new[26]	_	_
5-3	470-474	this	abstract[26]|place[27]	new[26]|new[27]	coref	6-6[37_27]
5-4	475-479	site	abstract[26]|place[27]	new[26]|new[27]	_	_
5-5	480-484	also	_	_	_	_
5-6	485-491	confer	_	_	_	_
5-7	492-502	resistance	abstract[28]	new[28]	coref	9-12[0_28]
5-8	503-505	to	abstract[28]	new[28]	_	_
5-9	506-511	other	abstract[28]|substance[29]	new[28]|new[29]	appos	5-14[30_29]
5-10	512-513	“	abstract[28]|substance[29]	new[28]|new[29]	_	_
5-11	514-525	antibiotics	abstract[28]|substance[29]	new[28]|new[29]	_	_
5-12	526-527	”	abstract[28]|substance[29]	new[28]|new[29]	_	_
5-13	528-529	[	_	_	_	_
5-14	530-534	e.g.	substance[30]	giv[30]	appos	5-18[0_30]
5-15	535-536	,	substance[30]	giv[30]	_	_
5-16	537-547	anisomycin	substance[30]	giv[30]	_	_
5-17	548-549	,	_	_	_	_
5-18	550-553	211	substance	giv	_	_
5-19	554-555	]	_	_	_	_
5-20	556-557	,	_	_	_	_
5-21	558-562	that	_	_	_	_
5-22	563-567	bind	_	_	_	_
5-23	568-571	the	abstract[32]	new[32]	_	_
5-24	572-578	A-site	abstract[32]	new[32]	_	_
5-25	579-581	of	abstract[32]	new[32]	_	_
5-26	582-585	the	abstract[32]|place[35]	new[32]|new[35]	_	_
5-27	586-594	peptidyl	abstract[32]|abstract|object[34]|place[35]	new[32]|new|new[34]|new[35]	coref	6-17
5-28	595-606	transferase	abstract[32]|object[34]|place[35]	new[32]|new[34]|new[35]	_	_
5-29	607-613	center	abstract[32]|place[35]	new[32]|new[35]	_	_
5-30	614-615	.	_	_	_	_

#Text=The W-finger projects directly into this site , and the RPL3 protein coordinates aa-tRNA accommodation , peptidyl transfer and translocation steps during protein translation .
6-1	616-619	The	abstract[36]	giv[36]	coref	9-6[0_36]
6-2	620-628	W-finger	abstract[36]	giv[36]	_	_
6-3	629-637	projects	_	_	_	_
6-4	638-646	directly	_	_	_	_
6-5	647-651	into	_	_	_	_
6-6	652-656	this	place[37]	giv[37]	_	_
6-7	657-661	site	place[37]	giv[37]	_	_
6-8	662-663	,	_	_	_	_
6-9	664-667	and	_	_	_	_
6-10	668-671	the	substance[39]	giv[39]	coref	6-23[0_39]
6-11	672-676	RPL3	abstract|substance[39]	giv|giv[39]	coref	10-4[83_0]
6-12	677-684	protein	substance[39]	giv[39]	_	_
6-13	685-696	coordinates	_	_	_	_
6-14	697-704	aa-tRNA	abstract|abstract[41]|abstract[45]	new|new[41]|new[45]	coref	8-12
6-15	705-718	accommodation	abstract[41]|abstract[45]	new[41]|new[45]	_	_
6-16	719-720	,	abstract[45]	new[45]	_	_
6-17	721-729	peptidyl	abstract|event[43]|abstract[45]	giv|new[43]|new[45]	_	_
6-18	730-738	transfer	event[43]|abstract[45]	new[43]|new[45]	_	_
6-19	739-742	and	abstract[45]	new[45]	_	_
6-20	743-756	translocation	place|abstract[45]	new|new[45]	_	_
6-21	757-762	steps	abstract[45]	new[45]	_	_
6-22	763-769	during	_	_	_	_
6-23	770-777	protein	substance|abstract[47]	giv|new[47]	coref|coref	8-26[0_47]|16-16[147_0]
6-24	778-789	translation	abstract[47]	new[47]	_	_
6-25	790-791	.	_	_	_	_

#Text=Only a few substitutions of the tryptophan in this position are viable , including substitutions with other aromatic residues , or with cysteine or arginine .
7-1	792-796	Only	abstract[48]	new[48]	_	_
7-2	797-798	a	abstract[48]	new[48]	_	_
7-3	799-802	few	abstract[48]	new[48]	_	_
7-4	803-816	substitutions	abstract[48]	new[48]	_	_
7-5	817-819	of	abstract[48]	new[48]	_	_
7-6	820-823	the	abstract[48]|substance[49]	new[48]|giv[49]	_	_
7-7	824-834	tryptophan	abstract[48]|substance[49]	new[48]|giv[49]	_	_
7-8	835-837	in	abstract[48]	new[48]	_	_
7-9	838-842	this	abstract[48]|abstract[50]	new[48]|new[50]	_	_
7-10	843-851	position	abstract[48]|abstract[50]	new[48]|new[50]	_	_
7-11	852-855	are	_	_	_	_
7-12	856-862	viable	_	_	_	_
7-13	863-864	,	_	_	_	_
7-14	865-874	including	_	_	_	_
7-15	875-888	substitutions	event[51]	new[51]	_	_
7-16	889-893	with	event[51]	new[51]	_	_
7-17	894-899	other	event[51]|object[52]	new[51]|new[52]	_	_
7-18	900-908	aromatic	event[51]|object[52]	new[51]|new[52]	_	_
7-19	909-917	residues	event[51]|object[52]	new[51]|new[52]	_	_
7-20	918-919	,	_	_	_	_
7-21	920-922	or	_	_	_	_
7-22	923-927	with	_	_	_	_
7-23	928-936	cysteine	substance	new	_	_
7-24	937-939	or	_	_	_	_
7-25	940-948	arginine	substance	new	_	_
7-26	949-950	.	_	_	_	_

#Text=Studies in yeast show that the W255C substitution increases affinity to aa-tRNA , and while this mutation is non-lethal , it does result in reduced translation efficiency .
8-1	951-958	Studies	abstract[55]	new[55]	_	_
8-2	959-961	in	abstract[55]	new[55]	_	_
8-3	962-967	yeast	abstract[55]|substance	new[55]|new	coref	12-27
8-4	968-972	show	_	_	_	_
8-5	973-977	that	_	_	_	_
8-6	978-981	the	abstract[58]	new[58]	_	_
8-7	982-987	W255C	abstract|abstract[58]	new|new[58]	_	_
8-8	988-1000	substitution	abstract[58]	new[58]	_	_
8-9	1001-1010	increases	_	_	_	_
8-10	1011-1019	affinity	abstract[59]	new[59]	_	_
8-11	1020-1022	to	abstract[59]	new[59]	_	_
8-12	1023-1030	aa-tRNA	abstract[59]|abstract	new[59]|giv	_	_
8-13	1031-1032	,	_	_	_	_
8-14	1033-1036	and	_	_	_	_
8-15	1037-1042	while	_	_	_	_
8-16	1043-1047	this	event[61]	giv[61]	ana	8-21[0_61]
8-17	1048-1056	mutation	event[61]	giv[61]	_	_
8-18	1057-1059	is	_	_	_	_
8-19	1060-1070	non-lethal	_	_	_	_
8-20	1071-1072	,	_	_	_	_
8-21	1073-1075	it	event	giv	_	_
8-22	1076-1080	does	_	_	_	_
8-23	1081-1087	result	_	_	_	_
8-24	1088-1090	in	_	_	_	_
8-25	1091-1098	reduced	abstract[64]	new[64]	ana	9-1[0_64]
8-26	1099-1110	translation	abstract|abstract[64]	giv|new[64]	coref	9-20
8-27	1111-1121	efficiency	abstract[64]	new[64]	_	_
8-28	1122-1123	.	_	_	_	_

#Text=It is not known whether W-finger mutations occur as a natural resistance mechanism in plants , although in vitro translation assays demonstrated that ribosomes isolated from the FHB-resistant cultivar , Frontana , exhibit a higher tolerance to DON than those isolated from the susceptible cultivar Cassavant .
9-1	1124-1126	It	abstract	giv	_	_
9-2	1127-1129	is	_	_	_	_
9-3	1130-1133	not	_	_	_	_
9-4	1134-1139	known	_	_	_	_
9-5	1140-1147	whether	_	_	_	_
9-6	1148-1156	W-finger	abstract|abstract[67]	giv|giv[67]	coref	11-13[90_0]
9-7	1157-1166	mutations	abstract[67]	giv[67]	_	_
9-8	1167-1172	occur	_	_	_	_
9-9	1173-1175	as	_	_	_	_
9-10	1176-1177	a	abstract[69]	new[69]	_	_
9-11	1178-1185	natural	abstract[69]	new[69]	_	_
9-12	1186-1196	resistance	abstract|abstract[69]	giv|new[69]	coref	13-24[112_0]
9-13	1197-1206	mechanism	abstract[69]	new[69]	_	_
9-14	1207-1209	in	_	_	_	_
9-15	1210-1216	plants	plant	new	coref	12-3[96_0]
9-16	1217-1218	,	_	_	_	_
9-17	1219-1227	although	_	_	_	_
9-18	1228-1230	in	_	_	_	_
9-19	1231-1236	vitro	organization|abstract[73]	new|new[73]	_	_
9-20	1237-1248	translation	abstract|abstract[73]	giv|new[73]	coref	21-17
9-21	1249-1255	assays	abstract[73]	new[73]	_	_
9-22	1256-1268	demonstrated	_	_	_	_
9-23	1269-1273	that	_	_	_	_
9-24	1274-1283	ribosomes	abstract[74]	new[74]	coref	21-6[198_74]
9-25	1284-1292	isolated	abstract[74]	new[74]	_	_
9-26	1293-1297	from	abstract[74]	new[74]	_	_
9-27	1298-1301	the	abstract[74]|abstract[76]	new[74]|new[76]	appos	9-31[0_76]
9-28	1302-1315	FHB-resistant	abstract[74]|person|abstract[76]	new[74]|new|new[76]	_	_
9-29	1316-1324	cultivar	abstract[74]|abstract[76]	new[74]|new[76]	_	_
9-30	1325-1326	,	_	_	_	_
9-31	1327-1335	Frontana	abstract	giv	coref	9-43[80_0]
9-32	1336-1337	,	_	_	_	_
9-33	1338-1345	exhibit	_	_	_	_
9-34	1346-1347	a	abstract[78]	new[78]	coref	13-15[108_78]
9-35	1348-1354	higher	abstract[78]	new[78]	_	_
9-36	1355-1364	tolerance	abstract[78]	new[78]	_	_
9-37	1365-1367	to	abstract[78]	new[78]	_	_
9-38	1368-1371	DON	abstract[78]|place	new[78]|new	coref	11-31
9-39	1372-1376	than	_	_	_	_
9-40	1377-1382	those	_	_	_	_
9-41	1383-1391	isolated	_	_	_	_
9-42	1392-1396	from	_	_	_	_
9-43	1397-1400	the	abstract[80]	giv[80]	_	_
9-44	1401-1412	susceptible	abstract[80]	giv[80]	_	_
9-45	1413-1421	cultivar	abstract[80]	giv[80]	_	_
9-46	1422-1431	Cassavant	abstract	new	_	_
9-47	1432-1433	.	_	_	_	_

#Text=Transgenic expression of modified RPL3 has had mixed results .
10-1	1434-1444	Transgenic	abstract[82]	new[82]	_	_
10-2	1445-1455	expression	abstract[82]	new[82]	_	_
10-3	1456-1458	of	abstract[82]	new[82]	_	_
10-4	1459-1467	modified	abstract[82]|abstract[83]	new[82]|giv[83]	ana	11-1[0_83]
10-5	1468-1472	RPL3	abstract[82]|abstract[83]	new[82]|giv[83]	_	_
10-6	1473-1476	has	_	_	_	_
10-7	1477-1480	had	_	_	_	_
10-8	1481-1486	mixed	abstract[84]	new[84]	_	_
10-9	1487-1494	results	abstract[84]	new[84]	_	_
10-10	1495-1496	.	_	_	_	_

#Text=It was determined that the expression of the tomato RPL3 gene with a modified W-finger ( W258C ) had a minimal effect on the ability of transgenic tobacco to tolerate DON .
11-1	1497-1499	It	abstract	giv	coref	12-10[97_0]
11-2	1500-1503	was	_	_	_	_
11-3	1504-1514	determined	_	_	_	_
11-4	1515-1519	that	_	_	_	_
11-5	1520-1523	the	abstract[86]	new[86]	_	_
11-6	1524-1534	expression	abstract[86]	new[86]	_	_
11-7	1535-1537	of	abstract[86]	new[86]	_	_
11-8	1538-1541	the	abstract[86]|abstract[89]	new[86]|new[89]	coref	15-25[134_89]
11-9	1542-1548	tomato	abstract[86]|plant|abstract[89]	new[86]|new|new[89]	_	_
11-10	1549-1553	RPL3	abstract[86]|person|abstract[89]	new[86]|new|new[89]	_	_
11-11	1554-1558	gene	abstract[86]|abstract[89]	new[86]|new[89]	_	_
11-12	1559-1563	with	abstract[86]|abstract[89]	new[86]|new[89]	_	_
11-13	1564-1565	a	abstract[86]|abstract[89]|abstract[90]	new[86]|new[89]|giv[90]	appos	11-17[0_90]
11-14	1566-1574	modified	abstract[86]|abstract[89]|abstract[90]	new[86]|new[89]|giv[90]	_	_
11-15	1575-1583	W-finger	abstract[86]|abstract[89]|abstract[90]	new[86]|new[89]|giv[90]	_	_
11-16	1584-1585	(	_	_	_	_
11-17	1586-1591	W258C	abstract	giv	coref	13-10
11-18	1592-1593	)	_	_	_	_
11-19	1594-1597	had	_	_	_	_
11-20	1598-1599	a	abstract[92]	giv[92]	_	_
11-21	1600-1607	minimal	abstract[92]	giv[92]	_	_
11-22	1608-1614	effect	abstract[92]	giv[92]	_	_
11-23	1615-1617	on	abstract[92]	giv[92]	_	_
11-24	1618-1621	the	abstract[92]|abstract[93]	giv[92]|new[93]	_	_
11-25	1622-1629	ability	abstract[92]|abstract[93]	giv[92]|new[93]	_	_
11-26	1630-1632	of	abstract[92]|abstract[93]	giv[92]|new[93]	_	_
11-27	1633-1643	transgenic	abstract[92]|abstract[93]|substance[94]	giv[92]|new[93]|new[94]	coref	13-18[0_94]
11-28	1644-1651	tobacco	abstract[92]|abstract[93]|substance[94]	giv[92]|new[93]|new[94]	_	_
11-29	1652-1654	to	abstract[92]|abstract[93]	giv[92]|new[93]	_	_
11-30	1655-1663	tolerate	abstract[92]|abstract[93]	giv[92]|new[93]	_	_
11-31	1664-1667	DON	abstract[92]|abstract[93]|place	giv[92]|new[93]|giv	coref	12-19
11-32	1668-1669	.	_	_	_	_

#Text=Additionally , transgenic plants were found to preferentially utilize the wild-type RPL3 ( except at sub-lethal concentrations of DON ) and these observations were corroborated using yeast transformants .
12-1	1670-1682	Additionally	_	_	_	_
12-2	1683-1684	,	_	_	_	_
12-3	1685-1695	transgenic	plant[96]	giv[96]	coref	15-31[135_96]
12-4	1696-1702	plants	plant[96]	giv[96]	_	_
12-5	1703-1707	were	_	_	_	_
12-6	1708-1713	found	_	_	_	_
12-7	1714-1716	to	_	_	_	_
12-8	1717-1731	preferentially	_	_	_	_
12-9	1732-1739	utilize	_	_	_	_
12-10	1740-1743	the	abstract[97]	giv[97]	coref	13-9[106_97]
12-11	1744-1753	wild-type	abstract[97]	giv[97]	_	_
12-12	1754-1758	RPL3	abstract[97]	giv[97]	_	_
12-13	1759-1760	(	_	_	_	_
12-14	1761-1767	except	_	_	_	_
12-15	1768-1770	at	_	_	_	_
12-16	1771-1781	sub-lethal	substance[98]	new[98]	_	_
12-17	1782-1796	concentrations	substance[98]	new[98]	_	_
12-18	1797-1799	of	substance[98]	new[98]	_	_
12-19	1800-1803	DON	substance[98]|place	new[98]|giv	coref	13-15
12-20	1804-1805	)	_	_	_	_
12-21	1806-1809	and	_	_	_	_
12-22	1810-1815	these	abstract[100]	new[100]	_	_
12-23	1816-1828	observations	abstract[100]	new[100]	_	_
12-24	1829-1833	were	_	_	_	_
12-25	1834-1846	corroborated	_	_	_	_
12-26	1847-1852	using	_	_	_	_
12-27	1853-1858	yeast	substance|abstract[102]	giv|new[102]	coref	14-17
12-28	1859-1872	transformants	abstract[102]	new[102]	_	_
12-29	1873-1874	.	_	_	_	_

#Text=On the other hand , transgenic expression of a W258C modified rice RPL3 conferred DON tolerance in tobacco protoplasts , as well as FEB resistance in maize .
13-1	1875-1877	On	_	_	_	_
13-2	1878-1881	the	_	_	_	_
13-3	1882-1887	other	_	_	_	_
13-4	1888-1892	hand	_	_	_	_
13-5	1893-1894	,	_	_	_	_
13-6	1895-1905	transgenic	abstract[103]	new[103]	_	_
13-7	1906-1916	expression	abstract[103]	new[103]	_	_
13-8	1917-1919	of	abstract[103]	new[103]	_	_
13-9	1920-1921	a	abstract[103]|abstract[106]	new[103]|giv[106]	coref	14-13[117_106]
13-10	1922-1927	W258C	abstract[103]|abstract|abstract[106]	new[103]|giv|giv[106]	_	_
13-11	1928-1936	modified	abstract[103]|abstract[106]	new[103]|giv[106]	_	_
13-12	1937-1941	rice	abstract[103]|substance|abstract[106]	new[103]|new|giv[106]	_	_
13-13	1942-1946	RPL3	abstract[103]|abstract[106]	new[103]|giv[106]	_	_
13-14	1947-1956	conferred	_	_	_	_
13-15	1957-1960	DON	place|abstract[108]	giv|giv[108]	coref|coref	14-20|16-43[157_108]
13-16	1961-1970	tolerance	abstract[108]	giv[108]	_	_
13-17	1971-1973	in	abstract[108]	giv[108]	_	_
13-18	1974-1981	tobacco	abstract[108]|substance|animal[110]	giv[108]|giv|new[110]	coref	16-26
13-19	1982-1993	protoplasts	abstract[108]|animal[110]	giv[108]|new[110]	_	_
13-20	1994-1995	,	_	_	_	_
13-21	1996-1998	as	_	_	_	_
13-22	1999-2003	well	_	_	_	_
13-23	2004-2006	as	_	_	_	_
13-24	2007-2010	FEB	event|abstract[112]	new|giv[112]	ana	14-1[0_112]
13-25	2011-2021	resistance	abstract[112]	giv[112]	_	_
13-26	2022-2024	in	abstract[112]	giv[112]	_	_
13-27	2025-2030	maize	abstract[112]|plant	giv[112]|new	_	_
13-28	2031-2032	.	_	_	_	_

#Text=It has also been suggested by Di et al. that expression of a truncated RPL3 from yeast could reduce DON toxicity in cereals by drawing the toxin away from the functional wild-type RPL3 .
14-1	2033-2035	It	abstract	giv	coref	18-37[177_0]
14-2	2036-2039	has	_	_	_	_
14-3	2040-2044	also	_	_	_	_
14-4	2045-2049	been	_	_	_	_
14-5	2050-2059	suggested	_	_	_	_
14-6	2060-2062	by	_	_	_	_
14-7	2063-2065	Di	person	new	_	_
14-8	2066-2068	et	_	_	_	_
14-9	2069-2072	al.	_	_	_	_
14-10	2073-2077	that	_	_	_	_
14-11	2078-2088	expression	abstract[116]	new[116]	_	_
14-12	2089-2091	of	abstract[116]	new[116]	_	_
14-13	2092-2093	a	abstract[116]|abstract[117]	new[116]|giv[117]	coref	14-30[124_117]
14-14	2094-2103	truncated	abstract[116]|abstract[117]	new[116]|giv[117]	_	_
14-15	2104-2108	RPL3	abstract[116]|abstract[117]	new[116]|giv[117]	_	_
14-16	2109-2113	from	abstract[116]|abstract[117]	new[116]|giv[117]	_	_
14-17	2114-2119	yeast	abstract[116]|abstract[117]|substance	new[116]|giv[117]|giv	coref	15-5
14-18	2120-2125	could	_	_	_	_
14-19	2126-2132	reduce	_	_	_	_
14-20	2133-2136	DON	place|abstract[120]	giv|new[120]	coref	15-42
14-21	2137-2145	toxicity	abstract[120]	new[120]	_	_
14-22	2146-2148	in	abstract[120]	new[120]	_	_
14-23	2149-2156	cereals	abstract[120]|plant	new[120]|new	_	_
14-24	2157-2159	by	_	_	_	_
14-25	2160-2167	drawing	_	_	_	_
14-26	2168-2171	the	substance[122]	new[122]	coref	22-28[210_122]
14-27	2172-2177	toxin	substance[122]	new[122]	_	_
14-28	2178-2182	away	_	_	_	_
14-29	2183-2187	from	_	_	_	_
14-30	2188-2191	the	abstract[124]	giv[124]	coref	15-4[127_124]
14-31	2192-2202	functional	abstract[124]	giv[124]	_	_
14-32	2203-2212	wild-type	abstract|abstract[124]	new|giv[124]	_	_
14-33	2213-2217	RPL3	abstract[124]	giv[124]	_	_
14-34	2218-2219	.	_	_	_	_

#Text=The authors expressed truncated yeast RPL3 ( ΔL3 ) in wheat and found that , in addition to an increase in the expression of the endogenous wheat RPL3 gene , transgenic plants displayed a reduction in FHB symptoms as well as DON accumulation .
15-1	2220-2223	The	person[125]	new[125]	_	_
15-2	2224-2231	authors	person[125]	new[125]	_	_
15-3	2232-2241	expressed	_	_	_	_
15-4	2242-2251	truncated	abstract[127]	giv[127]	appos	15-8[0_127]
15-5	2252-2257	yeast	substance|abstract[127]	giv|giv[127]	_	_
15-6	2258-2262	RPL3	abstract[127]	giv[127]	_	_
15-7	2263-2264	(	_	_	_	_
15-8	2265-2268	ΔL3	abstract	giv	coref	15-28
15-9	2269-2270	)	_	_	_	_
15-10	2271-2273	in	_	_	_	_
15-11	2274-2279	wheat	plant	new	coref	15-27
15-12	2280-2283	and	_	_	_	_
15-13	2284-2289	found	_	_	_	_
15-14	2290-2294	that	_	_	_	_
15-15	2295-2296	,	_	_	_	_
15-16	2297-2299	in	_	_	_	_
15-17	2300-2308	addition	_	_	_	_
15-18	2309-2311	to	_	_	_	_
15-19	2312-2314	an	event[130]	new[130]	_	_
15-20	2315-2323	increase	event[130]	new[130]	_	_
15-21	2324-2326	in	event[130]	new[130]	_	_
15-22	2327-2330	the	event[130]|abstract[131]	new[130]|new[131]	_	_
15-23	2331-2341	expression	event[130]|abstract[131]	new[130]|new[131]	_	_
15-24	2342-2344	of	event[130]|abstract[131]	new[130]|new[131]	_	_
15-25	2345-2348	the	event[130]|abstract[131]|abstract[134]	new[130]|new[131]|giv[134]	coref	16-33[154_134]
15-26	2349-2359	endogenous	event[130]|abstract[131]|abstract[134]	new[130]|new[131]|giv[134]	_	_
15-27	2360-2365	wheat	event[130]|abstract[131]|plant|abstract[134]	new[130]|new[131]|giv|giv[134]	coref	17-28
15-28	2366-2370	RPL3	event[130]|abstract[131]|abstract|abstract[134]	new[130]|new[131]|giv|giv[134]	coref	16-15
15-29	2371-2375	gene	event[130]|abstract[131]|abstract[134]	new[130]|new[131]|giv[134]	_	_
15-30	2376-2377	,	_	_	_	_
15-31	2378-2388	transgenic	plant[135]	giv[135]	_	_
15-32	2389-2395	plants	plant[135]	giv[135]	_	_
15-33	2396-2405	displayed	_	_	_	_
15-34	2406-2407	a	abstract[136]	new[136]	_	_
15-35	2408-2417	reduction	abstract[136]	new[136]	_	_
15-36	2418-2420	in	abstract[136]	new[136]	_	_
15-37	2421-2424	FHB	abstract[136]|abstract|abstract[138]	new[136]|new|new[138]	_	_
15-38	2425-2433	symptoms	abstract[136]|abstract[138]	new[136]|new[138]	_	_
15-39	2434-2436	as	abstract[136]	new[136]	_	_
15-40	2437-2441	well	abstract[136]	new[136]	_	_
15-41	2442-2444	as	abstract[136]	new[136]	_	_
15-42	2445-2448	DON	abstract[136]|place|event[140]	new[136]|giv|new[140]	coref	16-44
15-43	2449-2461	accumulation	abstract[136]|event[140]	new[136]|new[140]	_	_
15-44	2462-2463	.	_	_	_	_

#Text=In a similar study , the same group had earlier reported that co-expression of ΔL3 together with a Pokeweed Antiviral Protein ( PAP ) in tobacco cells resulted in increased expression of the host RPL3 gene , and this was coincident with improved DON tolerance .
16-1	2464-2466	In	_	_	_	_
16-2	2467-2468	a	abstract[141]	new[141]	coref	18-2[167_141]
16-3	2469-2476	similar	abstract[141]	new[141]	_	_
16-4	2477-2482	study	abstract[141]	new[141]	_	_
16-5	2483-2484	,	_	_	_	_
16-6	2485-2488	the	person[142]	new[142]	_	_
16-7	2489-2493	same	person[142]	new[142]	_	_
16-8	2494-2499	group	person[142]	new[142]	_	_
16-9	2500-2503	had	_	_	_	_
16-10	2504-2511	earlier	_	_	_	_
16-11	2512-2520	reported	_	_	_	_
16-12	2521-2525	that	_	_	_	_
16-13	2526-2539	co-expression	abstract[143]	new[143]	_	_
16-14	2540-2542	of	abstract[143]	new[143]	_	_
16-15	2543-2546	ΔL3	abstract[143]|abstract	new[143]|giv	coref	16-35
16-16	2547-2555	together	abstract[143]|substance[147]	new[143]|giv[147]	_	_
16-17	2556-2560	with	abstract[143]|substance[147]	new[143]|giv[147]	_	_
16-18	2561-2562	a	abstract[143]|substance[147]	new[143]|giv[147]	_	_
16-19	2563-2571	Pokeweed	abstract[143]|person|substance[147]	new[143]|new|giv[147]	_	_
16-20	2572-2581	Antiviral	abstract[143]|person|substance[147]	new[143]|new|giv[147]	_	_
16-21	2582-2589	Protein	abstract[143]|substance[147]	new[143]|giv[147]	_	_
16-22	2590-2591	(	_	_	_	_
16-23	2592-2595	PAP	abstract	new	_	_
16-24	2596-2597	)	_	_	_	_
16-25	2598-2600	in	_	_	_	_
16-26	2601-2608	tobacco	substance|animal[150]	giv|new[150]	_	_
16-27	2609-2614	cells	animal[150]	new[150]	_	_
16-28	2615-2623	resulted	_	_	_	_
16-29	2624-2626	in	_	_	_	_
16-30	2627-2636	increased	abstract[151]	new[151]	_	_
16-31	2637-2647	expression	abstract[151]	new[151]	_	_
16-32	2648-2650	of	abstract[151]	new[151]	_	_
16-33	2651-2654	the	abstract[151]|abstract[154]	new[151]|giv[154]	ana	16-39[0_154]
16-34	2655-2659	host	abstract[151]|animal|abstract[154]	new[151]|new|giv[154]	_	_
16-35	2660-2664	RPL3	abstract[151]|abstract|abstract[154]	new[151]|giv|giv[154]	_	_
16-36	2665-2669	gene	abstract[151]|abstract[154]	new[151]|giv[154]	_	_
16-37	2670-2671	,	_	_	_	_
16-38	2672-2675	and	_	_	_	_
16-39	2676-2680	this	abstract	giv	coref	20-12
16-40	2681-2684	was	_	_	_	_
16-41	2685-2695	coincident	_	_	_	_
16-42	2696-2700	with	_	_	_	_
16-43	2701-2709	improved	abstract[157]	giv[157]	ana	17-5[0_157]
16-44	2710-2713	DON	place|abstract[157]	giv|giv[157]	coref	17-25
16-45	2714-2723	tolerance	abstract[157]	giv[157]	_	_
16-46	2724-2725	.	_	_	_	_

#Text=In this context , it is interesting that the up-regulation of different components of the ribosome has been observed directly in response to exogenous DON applications in wheat .
17-1	2726-2728	In	_	_	_	_
17-2	2729-2733	this	abstract[158]	new[158]	_	_
17-3	2734-2741	context	abstract[158]	new[158]	_	_
17-4	2742-2743	,	_	_	_	_
17-5	2744-2746	it	abstract	giv	_	_
17-6	2747-2749	is	_	_	_	_
17-7	2750-2761	interesting	_	_	_	_
17-8	2762-2766	that	_	_	_	_
17-9	2767-2770	the	abstract[160]	new[160]	coref	19-7[179_160]
17-10	2771-2784	up-regulation	abstract[160]	new[160]	_	_
17-11	2785-2787	of	abstract[160]	new[160]	_	_
17-12	2788-2797	different	abstract[160]|abstract[161]	new[160]|new[161]	coref	18-15[171_161]
17-13	2798-2808	components	abstract[160]|abstract[161]	new[160]|new[161]	_	_
17-14	2809-2811	of	abstract[160]|abstract[161]	new[160]|new[161]	_	_
17-15	2812-2815	the	abstract[160]|abstract[161]|abstract[162]	new[160]|new[161]|giv[162]	coref	20-33[0_162]
17-16	2816-2824	ribosome	abstract[160]|abstract[161]|abstract[162]	new[160]|new[161]|giv[162]	_	_
17-17	2825-2828	has	_	_	_	_
17-18	2829-2833	been	_	_	_	_
17-19	2834-2842	observed	_	_	_	_
17-20	2843-2851	directly	_	_	_	_
17-21	2852-2854	in	_	_	_	_
17-22	2855-2863	response	_	_	_	_
17-23	2864-2866	to	_	_	_	_
17-24	2867-2876	exogenous	abstract[164]	new[164]	_	_
17-25	2877-2880	DON	place|abstract[164]	giv|new[164]	coref	18-10
17-26	2881-2893	applications	abstract[164]	new[164]	_	_
17-27	2894-2896	in	abstract[164]	new[164]	_	_
17-28	2897-2902	wheat	abstract[164]|plant	new[164]|giv	_	_
17-29	2903-2904	.	_	_	_	_

#Text=In a transcriptomics study by Foroud et al. , DON induced higher expression of ribosomal components , but only in the resistant genotypes , which incidentally were generated through a process that provides selection pressure for trichothecene resistance .
18-1	2905-2907	In	_	_	_	_
18-2	2908-2909	a	abstract[167]	giv[167]	_	_
18-3	2910-2925	transcriptomics	organization|abstract[167]	new|giv[167]	_	_
18-4	2926-2931	study	abstract[167]	giv[167]	_	_
18-5	2932-2934	by	abstract[167]	giv[167]	_	_
18-6	2935-2941	Foroud	abstract[167]|person	giv[167]|new	_	_
18-7	2942-2944	et	abstract[167]	giv[167]	_	_
18-8	2945-2948	al.	abstract[167]	giv[167]	_	_
18-9	2949-2950	,	_	_	_	_
18-10	2951-2954	DON	place	giv	_	_
18-11	2955-2962	induced	_	_	_	_
18-12	2963-2969	higher	abstract[170]	new[170]	coref	19-33[0_170]
18-13	2970-2980	expression	abstract[170]	new[170]	_	_
18-14	2981-2983	of	abstract[170]	new[170]	_	_
18-15	2984-2993	ribosomal	abstract[170]|abstract[171]	new[170]|giv[171]	_	_
18-16	2994-3004	components	abstract[170]|abstract[171]	new[170]|giv[171]	_	_
18-17	3005-3006	,	_	_	_	_
18-18	3007-3010	but	_	_	_	_
18-19	3011-3015	only	abstract[172]	new[172]	coref	19-38[187_172]
18-20	3016-3018	in	abstract[172]	new[172]	_	_
18-21	3019-3022	the	abstract[172]	new[172]	_	_
18-22	3023-3032	resistant	abstract[172]	new[172]	_	_
18-23	3033-3042	genotypes	abstract[172]	new[172]	_	_
18-24	3043-3044	,	abstract[172]	new[172]	_	_
18-25	3045-3050	which	abstract[172]	new[172]	_	_
18-26	3051-3063	incidentally	abstract[172]	new[172]	_	_
18-27	3064-3068	were	abstract[172]	new[172]	_	_
18-28	3069-3078	generated	abstract[172]	new[172]	_	_
18-29	3079-3086	through	abstract[172]	new[172]	_	_
18-30	3087-3088	a	abstract[172]|event[173]	new[172]|new[173]	_	_
18-31	3089-3096	process	abstract[172]|event[173]	new[172]|new[173]	_	_
18-32	3097-3101	that	abstract[172]|event[173]	new[172]|new[173]	_	_
18-33	3102-3110	provides	abstract[172]|event[173]	new[172]|new[173]	_	_
18-34	3111-3120	selection	abstract[172]|event[173]|abstract|abstract[175]	new[172]|new[173]|new|new[175]	_	_
18-35	3121-3129	pressure	abstract[172]|event[173]|abstract[175]	new[172]|new[173]|new[175]	_	_
18-36	3130-3133	for	abstract[172]|event[173]|abstract[175]	new[172]|new[173]|new[175]	_	_
18-37	3134-3147	trichothecene	abstract[172]|event[173]|abstract[175]|place|abstract[177]	new[172]|new[173]|new[175]|giv|giv[177]	coref	19-36[186_177]
18-38	3148-3158	resistance	abstract[172]|event[173]|abstract[175]|abstract[177]	new[172]|new[173]|new[175]|giv[177]	_	_
18-39	3159-3160	.	_	_	_	_

#Text=There are many potential explanations for this up-regulation , though at this stage only speculation can be offered , and it is also unknown whether there is a direct link with this expression pattern and resistance in these genotypes .
19-1	3161-3166	There	_	_	_	_
19-2	3167-3170	are	_	_	_	_
19-3	3171-3175	many	abstract[178]	new[178]	_	_
19-4	3176-3185	potential	abstract[178]	new[178]	_	_
19-5	3186-3198	explanations	abstract[178]	new[178]	_	_
19-6	3199-3202	for	abstract[178]	new[178]	_	_
19-7	3203-3207	this	abstract[178]|abstract[179]	new[178]|giv[179]	_	_
19-8	3208-3221	up-regulation	abstract[178]|abstract[179]	new[178]|giv[179]	_	_
19-9	3222-3223	,	_	_	_	_
19-10	3224-3230	though	_	_	_	_
19-11	3231-3233	at	_	_	_	_
19-12	3234-3238	this	abstract[180]	new[180]	_	_
19-13	3239-3244	stage	abstract[180]	new[180]	_	_
19-14	3245-3249	only	abstract[181]	new[181]	ana	19-21[0_181]
19-15	3250-3261	speculation	abstract[181]	new[181]	_	_
19-16	3262-3265	can	_	_	_	_
19-17	3266-3268	be	_	_	_	_
19-18	3269-3276	offered	_	_	_	_
19-19	3277-3278	,	_	_	_	_
19-20	3279-3282	and	_	_	_	_
19-21	3283-3285	it	abstract	giv	_	_
19-22	3286-3288	is	_	_	_	_
19-23	3289-3293	also	_	_	_	_
19-24	3294-3301	unknown	_	_	_	_
19-25	3302-3309	whether	_	_	_	_
19-26	3310-3315	there	_	_	_	_
19-27	3316-3318	is	_	_	_	_
19-28	3319-3320	a	abstract[183]	new[183]	_	_
19-29	3321-3327	direct	abstract[183]	new[183]	_	_
19-30	3328-3332	link	abstract[183]	new[183]	_	_
19-31	3333-3337	with	abstract[183]	new[183]	_	_
19-32	3338-3342	this	abstract[183]|abstract[185]	new[183]|new[185]	_	_
19-33	3343-3353	expression	abstract[183]|abstract|abstract[185]	new[183]|giv|new[185]	coref	20-11[191_0]
19-34	3354-3361	pattern	abstract[183]|abstract[185]	new[183]|new[185]	_	_
19-35	3362-3365	and	abstract[183]	new[183]	_	_
19-36	3366-3376	resistance	abstract[183]|abstract[186]	new[183]|giv[186]	ana	20-1[0_186]
19-37	3377-3379	in	abstract[183]|abstract[186]	new[183]|giv[186]	_	_
19-38	3380-3385	these	abstract[183]|abstract[186]|abstract[187]	new[183]|giv[186]|giv[187]	_	_
19-39	3386-3395	genotypes	abstract[183]|abstract[186]|abstract[187]	new[183]|giv[186]|giv[187]	_	_
19-40	3396-3397	.	_	_	_	_

#Text=It should be noted , however , that changes in ribosomal gene expression have been reported in different plant-pathogen interactions ( e.g. , ) , and importantly , according to the ‘ ribosome filter hypothesis ’
20-1	3398-3400	It	abstract	giv	coref	22-25[209_0]
20-2	3401-3407	should	_	_	_	_
20-3	3408-3410	be	_	_	_	_
20-4	3411-3416	noted	_	_	_	_
20-5	3417-3418	,	_	_	_	_
20-6	3419-3426	however	_	_	_	_
20-7	3427-3428	,	_	_	_	_
20-8	3429-3433	that	_	_	_	_
20-9	3434-3441	changes	abstract[189]	new[189]	coref	22-10[205_189]
20-10	3442-3444	in	abstract[189]	new[189]	_	_
20-11	3445-3454	ribosomal	abstract[189]|abstract[191]	new[189]|giv[191]	coref	22-15[207_191]
20-12	3455-3459	gene	abstract[189]|abstract|abstract[191]	new[189]|giv|giv[191]	coref	22-16
20-13	3460-3470	expression	abstract[189]|abstract[191]	new[189]|giv[191]	_	_
20-14	3471-3475	have	_	_	_	_
20-15	3476-3480	been	_	_	_	_
20-16	3481-3489	reported	_	_	_	_
20-17	3490-3492	in	_	_	_	_
20-18	3493-3502	different	abstract[192]	new[192]	_	_
20-19	3503-3517	plant-pathogen	abstract[192]	new[192]	_	_
20-20	3518-3530	interactions	abstract[192]	new[192]	_	_
20-21	3531-3532	(	_	_	_	_
20-22	3533-3537	e.g.	_	_	_	_
20-23	3538-3539	,	_	_	_	_
20-24	3540-3541	)	_	_	_	_
20-25	3542-3543	,	_	_	_	_
20-26	3544-3547	and	_	_	_	_
20-27	3548-3559	importantly	_	_	_	_
20-28	3560-3561	,	_	_	_	_
20-29	3562-3571	according	_	_	_	_
20-30	3572-3574	to	_	_	_	_
20-31	3575-3578	the	abstract[195]	new[195]	coref	22-3[203_195]
20-32	3579-3580	‘	abstract[195]	new[195]	_	_
20-33	3581-3589	ribosome	abstract|abstract[194]|abstract[195]	giv|new[194]|new[195]	coref	22-4[0_194]
20-34	3590-3596	filter	abstract[194]|abstract[195]	new[194]|new[195]	_	_
20-35	3597-3607	hypothesis	abstract[195]	new[195]	_	_
20-36	3608-3609	’	abstract[195]	new[195]	_	_

#Text=alterations in ribosomal composition or specialized ribosomes are thought to bias incorporation of specific mRNAs to translation .
21-1	3610-3621	alterations	abstract[196]	new[196]	_	_
21-2	3622-3624	in	abstract[196]	new[196]	_	_
21-3	3625-3634	ribosomal	abstract[196]|abstract[197]	new[196]|new[197]	_	_
21-4	3635-3646	composition	abstract[196]|abstract[197]	new[196]|new[197]	_	_
21-5	3647-3649	or	abstract[196]	new[196]	_	_
21-6	3650-3661	specialized	abstract[196]|abstract[198]	new[196]|giv[198]	_	_
21-7	3662-3671	ribosomes	abstract[196]|abstract[198]	new[196]|giv[198]	_	_
21-8	3672-3675	are	_	_	_	_
21-9	3676-3683	thought	_	_	_	_
21-10	3684-3686	to	_	_	_	_
21-11	3687-3691	bias	_	_	_	_
21-12	3692-3705	incorporation	event[199]	new[199]	_	_
21-13	3706-3708	of	event[199]	new[199]	_	_
21-14	3709-3717	specific	event[199]|abstract[200]	new[199]|new[200]	_	_
21-15	3718-3723	mRNAs	event[199]|abstract[200]	new[199]|new[200]	_	_
21-16	3724-3726	to	_	_	_	_
21-17	3727-3738	translation	abstract	giv	coref	22-20[208_0]
21-18	3739-3740	.	_	_	_	_

#Text=Thus , the filter hypothesis offers the possibility that the reported DON-induced changes in ribosomal gene expression might coordinate defense-related translation rather than conferring ribosomal resistance to the toxin .
22-1	3741-3745	Thus	_	_	_	_
22-2	3746-3747	,	_	_	_	_
22-3	3748-3751	the	abstract[203]	giv[203]	_	_
22-4	3752-3758	filter	abstract|abstract[203]	giv|giv[203]	_	_
22-5	3759-3769	hypothesis	abstract[203]	giv[203]	_	_
22-6	3770-3776	offers	_	_	_	_
22-7	3777-3780	the	abstract[204]	new[204]	_	_
22-8	3781-3792	possibility	abstract[204]	new[204]	_	_
22-9	3793-3797	that	abstract[204]	new[204]	_	_
22-10	3798-3801	the	abstract[204]|abstract[205]	new[204]|giv[205]	_	_
22-11	3802-3810	reported	abstract[204]|abstract[205]	new[204]|giv[205]	_	_
22-12	3811-3822	DON-induced	abstract[204]|abstract[205]	new[204]|giv[205]	_	_
22-13	3823-3830	changes	abstract[204]|abstract[205]	new[204]|giv[205]	_	_
22-14	3831-3833	in	abstract[204]|abstract[205]	new[204]|giv[205]	_	_
22-15	3834-3843	ribosomal	abstract[204]|abstract[205]|abstract[207]	new[204]|giv[205]|giv[207]	_	_
22-16	3844-3848	gene	abstract[204]|abstract[205]|abstract|abstract[207]	new[204]|giv[205]|giv|giv[207]	_	_
22-17	3849-3859	expression	abstract[204]|abstract[205]|abstract[207]	new[204]|giv[205]|giv[207]	_	_
22-18	3860-3865	might	abstract[204]	new[204]	_	_
22-19	3866-3876	coordinate	abstract[204]	new[204]	_	_
22-20	3877-3892	defense-related	abstract[204]|abstract[208]	new[204]|giv[208]	_	_
22-21	3893-3904	translation	abstract[204]|abstract[208]	new[204]|giv[208]	_	_
22-22	3905-3911	rather	abstract[204]	new[204]	_	_
22-23	3912-3916	than	abstract[204]	new[204]	_	_
22-24	3917-3927	conferring	abstract[204]	new[204]	_	_
22-25	3928-3937	ribosomal	abstract[204]|abstract[209]	new[204]|giv[209]	_	_
22-26	3938-3948	resistance	abstract[204]|abstract[209]	new[204]|giv[209]	_	_
22-27	3949-3951	to	abstract[204]|abstract[209]	new[204]|giv[209]	_	_
22-28	3952-3955	the	abstract[204]|abstract[209]|substance[210]	new[204]|giv[209]|giv[210]	_	_
22-29	3956-3961	toxin	abstract[204]|abstract[209]|substance[210]	new[204]|giv[209]|giv[210]	_	_
22-30	3962-3963	.	_	_	_	_
